Related references
Note: Only part of the references are listed.Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Evelien de Jong et al.
LANCET INFECTIOUS DISEASES (2016)
International Study on Microcirculatory Shock Occurrence in Acutely Ill Patients
Namkje A. R. Vellinga et al.
CRITICAL CARE MEDICINE (2015)
Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome
Anil Sapru et al.
INTENSIVE CARE MEDICINE (2015)
Study of acute hemocoagulation changes in a porcine endotoxemic shock model using thrombelastography
Joseph L. Nates et al.
TRANSLATIONAL RESEARCH (2015)
Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study
Anna Rautanen et al.
LANCET RESPIRATORY MEDICINE (2015)
Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation
Jean-Marie Forel et al.
INTENSIVE CARE MEDICINE (2015)
Integrative Omic Analysis of Experimental Bacteremia Identifies a Metabolic Signature That Distinguishes Human Sepsis from Systemic Inflammatory Response Syndromes
Raymond J. Langley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: A prospective study
Sisse R. Ostrowski et al.
JOURNAL OF CRITICAL CARE (2013)
Severe Sepsis and Septic Shock REPLY
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome
Lorraine B. Ware et al.
CRITICAL CARE (2013)
Severe Sepsis and Septic Shock
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial
Jens U. Jensen et al.
CRITICAL CARE MEDICINE (2011)
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Lila Bouadma et al.
LANCET (2010)
Share Paper
